NERI, Sergio
 Distribuzione geografica
Continente #
NA - Nord America 9.012
EU - Europa 4.313
AS - Asia 4.151
SA - Sud America 815
AF - Africa 502
Continente sconosciuto - Info sul continente non disponibili 295
OC - Oceania 9
Totale 19.097
Nazione #
US - Stati Uniti d'America 8.609
SG - Singapore 2.192
RU - Federazione Russa 1.249
CN - Cina 1.143
UA - Ucraina 828
IE - Irlanda 758
IT - Italia 688
BR - Brasile 654
CA - Canada 332
VN - Vietnam 313
CI - Costa d'Avorio 245
FR - Francia 240
SE - Svezia 147
NG - Nigeria 135
GB - Regno Unito 122
KR - Corea 96
IN - India 91
BD - Bangladesh 74
DE - Germania 73
AR - Argentina 51
SN - Senegal 40
MX - Messico 33
TR - Turchia 32
HK - Hong Kong 31
CO - Colombia 30
IQ - Iraq 29
NL - Olanda 29
PL - Polonia 29
ZA - Sudafrica 25
AT - Austria 23
CH - Svizzera 21
EC - Ecuador 20
VE - Venezuela 20
JP - Giappone 19
BE - Belgio 18
MA - Marocco 17
FI - Finlandia 16
UZ - Uzbekistan 16
ES - Italia 14
PK - Pakistan 13
PY - Paraguay 13
BG - Bulgaria 11
MY - Malesia 11
CL - Cile 10
CZ - Repubblica Ceca 10
KE - Kenya 10
EU - Europa 9
GR - Grecia 9
IR - Iran 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
ID - Indonesia 8
SA - Arabia Saudita 8
HN - Honduras 7
NP - Nepal 7
PH - Filippine 7
UY - Uruguay 7
JO - Giordania 6
TN - Tunisia 6
DZ - Algeria 5
EG - Egitto 5
GT - Guatemala 5
IL - Israele 5
KZ - Kazakistan 5
RO - Romania 5
GH - Ghana 4
LB - Libano 4
LT - Lituania 4
OM - Oman 4
PE - Perù 4
PR - Porto Rico 4
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
JM - Giamaica 3
KG - Kirghizistan 3
PA - Panama 3
SR - Suriname 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BS - Bahamas 2
DK - Danimarca 2
HR - Croazia 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
Totale 18.798
Città #
Dallas 1.379
Singapore 1.238
Santa Clara 1.020
Jacksonville 823
Dublin 752
Chandler 689
San Jose 566
Moscow 456
Chicago 355
Ashburn 350
Boardman 323
Nanjing 251
Abidjan 245
Toronto 226
Lawrence 211
Cambridge 208
Andover 206
Lauterbourg 186
Houston 176
Beijing 169
Los Angeles 166
Council Bluffs 163
Civitanova Marche 124
Ho Chi Minh City 110
San Mateo 107
Catania 105
Des Moines 104
Seoul 94
Abuja 86
Hefei 85
Wilmington 85
Nanchang 75
Hanoi 72
São Paulo 63
New York 62
Shenyang 61
Hebei 57
Saint Petersburg 55
Jiaxing 49
Ottawa 47
Buffalo 46
Changsha 46
Milan 46
Dakar 40
Tianjin 38
Lagos 36
Civitavecchia 29
Brooklyn 24
Montreal 23
Orem 23
The Dalles 23
Hong Kong 22
Rome 21
Seattle 21
Columbus 20
Warsaw 19
Brussels 18
Da Nang 18
Johannesburg 18
Tokyo 18
Belo Horizonte 17
Bremen 17
Baghdad 15
Boston 15
Chennai 15
Denver 15
Jinan 15
Kunming 15
Poplar 15
Rio de Janeiro 15
Haiphong 14
London 14
Pune 14
Ann Arbor 13
Atlanta 13
Leawood 13
Port Harcourt 13
San Francisco 13
Hangzhou 12
Hyderabad 12
Ankara 11
Buenos Aires 11
Curitiba 11
Redondo Beach 11
Augusta 10
Brasília 10
Dhaka 10
Mexico City 10
Mumbai 10
Ribeirão Preto 10
Washington 10
Amsterdam 9
Munich 9
Palermo 9
Phoenix 9
Porto Alegre 9
Secaucus 9
Shanghai 9
Stockholm 9
Elk Grove Village 8
Totale 12.627
Nome #
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis 340
Assessing degree of hepatic fibrosis in patients with chronic liver disease using gadoxetic acid-enhanced liver MRI: Preliminary results 185
LA DIAGNOSI DELLA SINDROME DELL'ARTERIA MESENTERICA SUPERIORE 180
A randomized, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment of patients with peripheral arterial disease and haemodialysis with propyonil L-carnitine 179
Acquired angioedema of the glottis, larynx and neck in a patient affected by SLE: case report 172
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 170
Carotid Intima-Media Thickness and Liver Histology in Hemodialysis Patients with Non-Alcoholic Fatty Liver Disease 169
Immune response in addicts with chronic hepatitis C treated with interferon and ribavirine 161
Acute renal failure in Plasmodium malariae infection 161
An unusual case of post-trasfusion malaria 159
Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study 154
Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis 153
Eterozigosi H36D per Emocromatosi in pazienti affetti da Steatoepatite e Epatite cronica da virus C 149
A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin 148
Obesity and related diseases: an epidemiologic study in Eastern Sicily 147
Association Between Diabetes Mellitus, Hepatic Steatosis And Fibrosis In Chronic Hepatitis C Patients 145
A therapeutic education and medical support program improves adherence to therapy with peg-interferon plus ribavirin therapy and increases sustained virological response in patients with chronic hepatitis C 144
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 144
An unusual case of genodermatosis with familial gastrointestinal polyposis, angiomatous malformation and ascites 140
Addome 140
A case of Overlap Syndrome:Autoimmune idiopatic hepatitis/pulmonary idiopatic hypertension 140
A hyperdynamic portal syndrome with ascites after endoscopic laser treatment 137
Organic or psychiatric disease? A misdiagnosed superior mesenteric artery syndrome 136
Carbohydrate 19-9 antigen in chronic viral hepatitis without neoplasia is associated with the severity of liver disease 136
AN UNUSUAL CASE OF GENODERMATOSE WITH FAMILIAL GASTROINTESTINAL POLYPOSIS, ANGIOMATOUS MALFORMATION AND ASCITES 135
Alteration of oxide-reductive and haemostatic factors in type 2 diabetics 134
Behaviour of some indicators of oxidative stress in postmenopausal and fertile women 134
A case of acute abdomen for the internist 133
Acetyl L-carnitine (ACL) treatment in elderly patients with fatigue 132
Fibrosi polmonare idiopatica: caso clinico [Idiopathic pulmonary fibrosis. A case report] 131
Effect of LPC on functional parameters and oxidative profile in type 2 diabetes-associated PAD 131
A STUDY OF CUPREMIA IN A GROUP OF ELDERLY DIABETICS 129
Vision loss due to atypical bilateral edema of the optic nerve in a patient with hereditary angioedema: A case report 127
A case of progression from type II cryoglobulinaemia to Waldenstrom's macroglobulinaemia in a patient with chronic hepatitis C 127
ON-TREATMENT SERUM HBsAG DECLINE DURING TELBIVUDINE THERAPY IN NAÏVE CHRONIC HEPATITIS B: CASE REPORT 126
Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects 126
A nationawide survey of hereditary angioedema due to C1 inhibitor defciency in Italy 125
PATOLOGIA JATROGENA ACUTA IN CORSO DI IPERTENSIONE POLMONARE CRONICA(CUORE POLMONARE CRONICO. CONSIDERAZIONI A PROPOSITO DI UNA OSSERVAZIONE PERSONALE 125
Verrucous Psoriasis in a Patient with Chronic C Hepatitis Treated with Interferon 123
An Unusual Case of Cerebral Oedema 122
Eritropoietina nel trattamento dell'anemia secondaria a terapia con interferone peghilato e ribavirina 121
Rosuvastatin reduces non alcoholic fatty liver diseasa in patients with chronic hepatitis C treated with alpha-interferon and ribavirin 120
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 118
Duration of menopause and behaviour of malondialdehyde, lipids, lipoproteins and carotid wall artery intima – media thickness 117
The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations 116
Changes in splenoportal axis calibre and flow in a patient affected by hereditary angioedema 113
Trattamento con peg-interferone e ribavirina nell’epatite cronica attiva C ed insorgenza di malattia celiaca: esiste una relazione ? 112
Duration of menopause and behaviour of malondialdehyde, lipids, lipoproteins and carotid wall intima-media thickenss 111
Eritropoietina nel trattamento dell’anemia secondaria a terapia con interferone peghilato e ribavirina 108
The Relationship between Body Dissatisfaction and Eating Disorder Symptoms in Young Women Aspiring Fashion Models: The Mediating Role of Stress 105
Endothelin-1 and endothelial damage in elderly patients 105
Diagnostic abd therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the italian experience 104
Oxidative stress, nitric oxide, endothelial dysfunction and tinnitus 101
Co-administration ezetimibe/simvastatin teraphy decrease the supersaturation in gallbladder bile and prevent cholesterol gallstones formation 101
CO-ADMINISTRATION EZETIMIBE/SIMVASTATIN TERAPHY DECREASES THE SUPER-SATURATION IN GALLBLADDER BILE AND PREVENT CHOLESTEROL GALLSTONES FORMATION 100
Ferro e ferrodeplezione nell'epatite cronica HCV-correlata 100
ON-TREATMENT HBsAg DECLINE IS ASSOCIATED WITH SUBSEQUENT HBsAg REDUCTION IN HBeAg NEGATIVE CHRONIC HEPATITIS B 100
Angioedema ereditario da carenza di C1 inibitore. Consensus italiano per la diagnosi e la terapia 98
POST-LOAD INSULIN RESISTANCE IS AN INDEPENDENT PREDICTOR OF HEPATIC FIBROSIS IN DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 98
Endothelin-1 in arterial hypertension after cold pressor test 97
Ferro e ferrodeplezione nell'epatite cronica HCV-correlata.Studio pilota 97
Role of Ademetionine (S-Adenosylmethionine) in cyclosporin-induced cholestasis 96
Un raro caso di epatite acuta da farmaci 95
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. 95
La metalloproteinasi-2 è un marker indiretto di citonecrosi e fibrosi epatica nell’epatite cronica HCV-correlata 95
Does endothelin-1 play a role in the renal function of cirrhotic patients? 94
Ultrasonography in diagnosis and evaluation of fibrocystic liver disease: two case reports 94
Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria 94
COMPLICATION AND HOSPITALISATION AFTER PERCUTANEOUS LIVER BIOPSY: A COHORT STUDY OF 12 YARS 94
INFEZIONE DA HAV IN PAZIENTI CON EPATITE CRONICA HCV-CORRELATA 94
Isomorphic response in eruptive xanthomas 93
Visceral adipose tissue area as independent risk factor of elevated alanine aminotransferase 92
Pegylated-interferon and ribavirin therapy of HCV-related type II mixed cryoglobulinemia 92
Evaluation of circulating CD4⁺CD25⁺ and liver-infiltrating Foxp3⁺ cells in HCV-associated liver disease 91
Iron depletion and lifestyle modifications improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia 91
PRELIEVO VENOSO RENALE PER IL DOSAGGIO DELLA PRA IN SOGGETTI CON IPERTENSIONE SISTO-DIASTOLICA E QUADRI ARTERIOGRAFICI SUGGESTIVI PER LESIONI VASCULO-PARENCHIMALI RENALI 91
URSODEOXYCHOLIC ACID AND SIMVASTATIN IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME 91
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group 90
CONTRIBUTO SUL COMPORTAMENTO DELLA MIOGLOBINEMIA NELL'IMA: CORRELAZIONI SIERO-ENZIMATICHE, SIGNIFICATO CLINICO. PARTE I. STUDIO IN UNA CASISTICA SELEZIONATA DI SOGGETTI CON IMA IN FASE PRECOCE 89
Drug Rash With Eosinophilia and Systemic Signs Syndrome in a Patient With Multiple Sclerosis 89
Combination therapy with pegylated-Interferon and Ribavirin determines a decrease in Squamous Cell Carcinoma Antigen (SCCA)-Immunoglobulin M (IgM) complex (SCCA-IgM IC) serum levels in patients with HCV-related liver cirrhosis 89
Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis 89
Relation of non-alcoholic hepatic steatosis to early carotid atherosclerosis in diet-controlled impaired glucose tolerance subjects 88
Diagnosis of renovascular disease by extra-end intrarenal doppler parameters 88
Steatohepatites Influence The Cardiovascular And Diabetus Mellitul Risk Profile 88
Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes 88
Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers 88
Infections: Patients with Peripheral Arterial Disease and Those with Risk Factors for Cardiovascular Diseases Compared to Normal Subjects 88
PERIHEPATIC LYMPHADENOPATHY IN CHRONIC C HAPATITIS; A COMPLEMENTARY DIAGNOSTIC ELEMENT? 86
Un caso di acidosi tubulare da causa jatrogena 86
Oxidative stress and white blood cell activation in chronic and severe ischemia of peripheral vascular disease 85
Biliary hamartomas (von Mayenburg complex): magnetic resonance imaging in a case report 84
Gordon’s Sindrome: A Case Report 84
URSODEOXYCHOLIC ACID AND SIMVASTATIN IN PATIENTS WITHNONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME 84
Propyonil-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease (PAD) and end stage renal disease (ESRD) 84
Isotretinoin in Perifolliculitis capitis abscedens et suffodiens: A case report and review of the literature 83
Infezione da HAV in pazienti con epatite cronica HCV correlata 83
Microalbuminuria nel diabete melliito tipo 2: prevalenza e correlazioni cliniche 83
The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin. 82
Effects of antioxidants on postprandial oxidative stress and endothelial dysfunction in subjects with impaired glucose tolerance and Type II diabetes 82
Totale 11.663
Categoria #
all - tutte 65.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.292 0 219 11 31 229 6 219 53 137 1 58 328
2022/20232.211 227 86 28 166 234 393 7 376 557 27 74 36
2023/2024846 57 135 40 52 51 124 26 39 4 20 215 83
2024/20253.694 54 650 223 190 768 472 84 151 267 368 189 278
2025/20267.106 452 271 1.518 399 1.139 1.364 948 130 352 269 168 96
2026/2027494 157 337 0 0 0 0 0 0 0 0 0 0
Totale 19.097